These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 35045888)

  • 1. Clinical efficacy of iodine complex in SARS-CoV-2-infected patients with mild to moderate symptoms: study protocol for a randomized controlled trial.
    Ashraf S; Ashraf S; Ashraf M; Farooq I; Akmal R; Imran MA; Kalsoom L; Ashraf S; Rafique S; Ghufran M; Akram MK; Sohaib-Ur-Rehman ; Nadeem MF; Matti N; Siddiqui UN; Humayun A; Saboor QA; Ahmad A; Ashraf M; Izhar M;
    Trials; 2022 Jan; 23(1):58. PubMed ID: 35045888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quadruple blinded placebo controlled randomised trial to evaluate the effectiveness of an Iodine complex for patients with mild to moderate COVID-19 in Pakistan (I-COVID-PK): A structured summary of a study protocol for a randomised controlled trial.
    Ashraf S; Ashraf S; Ashraf M; Imran MA; Kalsoom L; Siddiqui UN; Farooq I; Ghufran M; Khokhar RA; Akram MK; Shahid I; Sohaib Ur Rehman M; Akmal R; Tahir A; Zahid A; Ashraf S; Rafique S; Matti N; Nadeem MF; Humayun A; Malik A; Saboor QA; Ahmad A; Ashraf M; Izhar M
    Trials; 2021 Feb; 22(1):127. PubMed ID: 33568226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
    Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
    Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial.
    Manomaipiboon A; Pholtawornkulchai K; Poopipatpab S; Suraamornkul S; Maneerit J; Ruksakul W; Phumisantiphong U; Trakarnvanich T
    Trials; 2022 Aug; 23(1):714. PubMed ID: 36028897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, Double-Blind, Placebo-Controlled Trial of a Throat Spray with Selected Lactobacilli in COVID-19 Outpatients.
    De Boeck I; Cauwenberghs E; Spacova I; Gehrmann T; Eilers T; Delanghe L; Wittouck S; Bron PA; Henkens T; Gamgami I; Simons A; Claes I; Mariën J; Ariën KK; Bakokimi D; Loens K; Jacobs K; Ieven M; Bruijning-Verhagen P; Delputte P; Coenen S; Verhoeven V; Lebeer S
    Microbiol Spectr; 2022 Oct; 10(5):e0168222. PubMed ID: 36154666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study protocol for a double-blind randomised placebo-controlled trial evaluating the efficacy of carrageenan nasal and throat spray for COVID-19 prophylaxis-ICE-COVID.
    Jessop ZM; Gibson J; Lim JY; Jovic TH; Combellack E; Dobbs TD; Carter K; Hiles S; Islam S; Healy B; Humphreys I; Eccles R; Hutchings HA; Whitaker IS
    Trials; 2022 Sep; 23(1):782. PubMed ID: 36109791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling.
    Deckert A; Anders S; De Allegri M; Nguyen HT; Souares A; McMahon S; Meurer M; Burk R; Sand M; Koeppel L; Hein LM; Roß T; Adler T; Siems T; Brugnara L; Brenner S; Herbst K; Kirrmaier D; Duan Y; Ovchinnikova S; Boerner K; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Sep; 22(1):656. PubMed ID: 34565421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19-Results From a Pilot Open-Label, Randomized Controlled Trial.
    Khan A; Iqtadar S; Mumtaz SU; Heinrich M; Pascual-Figal DA; Livingstone S; Abaidullah S
    Front Pharmacol; 2022; 13():898062. PubMed ID: 35747751
    [No Abstract]   [Full Text] [Related]  

  • 9. Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multicenter placebo-controlled randomized clinical trial.
    Ashraf S; Ashraf S; Ashraf M; Imran MA; Kalsoom L; Siddiqui UN; Farooq I; Akmal R; Akram MK; Ashraf S; Ghufran M; Majeed N; Habib Z; Rafique S; -Abdin ZU; Arshad S; Shahab MS; Ahmad S; Zheng H; Mirza AR; Zulfiqar S; Anwar MI; Humayun A; Mahmud T; Saboor QA; Ahmad A; Ashraf M; Izhar M;
    Phytother Res; 2023 Feb; 37(2):627-644. PubMed ID: 36420866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of Recovery and Symptomatic Efficacy of a Polyherbal AYUSH Formulation in the Treatment of SARS-CoV-2 Disease: A Single-arm Trial.
    Kanchibhotla D; Harsora P; Subramanian S; Reddy MRK; Venkatesh HKR
    Altern Ther Health Med; 2023 May; 29(4):134-139. PubMed ID: 35951065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achyrocline satureioides as an adjuvant therapy for the management of mild viral respiratory infections in the context of COVID-19: Preliminary results of a randomized, placebo-controlled, and open-label clinical trial.
    Bastos CIM; Dani C; Cechinel LR; da Silva Neves AH; Rasia FB; Bianchi SE; da Silveira Loss E; Lamers ML; Meirelles G; Bassani VL; Siqueira IR
    Phytother Res; 2023 Nov; 37(11):5354-5365. PubMed ID: 37583121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: an open-label randomized clinical trial.
    Arefin MK; Rumi SKNF; Uddin AKMN; Banu SS; Khan M; Kaiser A; Chowdhury JA; Khan MAS; Hasan MJ
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2963-2967. PubMed ID: 34026595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the Unani Regimen as an Add-On to Standard Treatment in Hospitalised RT-PCR-Confirmed Mild to Moderate COVID-19 Patients: An Open-Label Randomized Controlled Trial.
    Kishore J; Kumar R; Nazli T; Ahmad A; Kumar P; Khan AA
    Cureus; 2023 May; 15(5):e38574. PubMed ID: 37284399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virucidal Effect of Povidone Iodine on SARS-CoV-2 in Nasopharynx: An Open-label Randomized Clinical Trial.
    Kamal Arefin M; Banu SS; Nasir Uddin AKM; Nurul Fattah Rumi SK; Khan M; Kaiser A; Arafat MS; Chowdhury JA; Khan MAS; Hasan MJ
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3283-3292. PubMed ID: 35572740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings.
    Noor NM; Pett SL; Esmail H; Crook AM; Vale CL; Sydes MR; Parmar MKB
    F1000Res; 2020; 9():1109. PubMed ID: 33149899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India.
    Singh H; Srivastava S; Yadav B; Rai AK; Jameela S; Muralidharan S; Mohan R; Chaudhary S; Singhal R; Rana R; Khanduri S; Sharma BS; Chandrasekhararao B; Srikanth N; Chaturvedi S
    Complement Ther Med; 2022 Jun; 66():102814. PubMed ID: 35149205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II Trial of the Impact 0.5% Povidone-Iodine Nasal Spray (Nasodine®) on Shedding of SARS-CoV-2.
    Friedland PL; Tucker S
    Laryngoscope; 2024 Mar; ():. PubMed ID: 38554057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 0.5% povidone-iodine on the nasopharyngeal and oropharyngeal viral loads in patients with COVID-19: A double-blind placebo-controlled randomized clinical trial.
    Sharma P; Singh A; Singh NP; Takhelchangbam N; Kumar R; Yadav R
    J Family Med Prim Care; 2022 Oct; 11(10):6320-6326. PubMed ID: 36618132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients.
    Ravichandran R; Mohan SK; Sukumaran SK; Kamaraj D; Daivasuga SS; Ravi SOAS; Vijayaraghavalu S; Kumar RK
    Sci Rep; 2022 Apr; 12(1):6413. PubMed ID: 35440611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prospective Study of AFree Oral Spray as an Adjuvant Therapy for Mild and Moderate COVID-19 in Community Health Stations: Clinical Progression and Viral Clearance Outcomes.
    Tran DT; Pham TN; Nguyen NH; Tran HD; Hoang HQ; Han BO; Hoang BX
    In Vivo; 2023; 37(5):2155-2160. PubMed ID: 37652493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.